control group:Standard first line treatment
Sponsors
Fudan University Shanghai Cancer Center, The First Affiliated Hospital with Nanjing Medical University
Conditions
Renal cell carcinomaneuroendocrine tumor
Early Phase 1
Combination of multi-omics study and FasterPDTX artificial microenvironment guides individual precise treatment of renal cell carcinoma — development and application of a new clinical model
RecruitingChiCTR2000036949
Start: 2020-10-01Updated: 2020-10-05
A multi-center clinical collaborative study on pharmacodynamic testing of Patient-Derived Tumor Xenograft (FastPDTX) to guide individualized treatment of neuroendocrine tumors
RecruitingChiCTR2100043124
Start: 2021-02-08Updated: 2021-05-24